BENEVICH ERIC - Insider Transactions
Insider Type
individual
Companies
1
Average
1,741,386
Total Txns
14
Long-Term
Annual Transaction Insights
| Year | Buy | Sell | Δ | Buy, USD | Sell, USD | Δ |
|---|---|---|---|---|---|---|
| 2024 | 0 | 10 | -10 | 0.00 | 23,827,440.44 | -23,827,440.44 |
| 2025 | 0 | 4 | -4 | 0.00 | 551,966.59 | -551,966.59 |
| Total: | 0 | 14 | 10 | 0.00 | 24,379,407.03 | -24,379,407.03 |
Transactions
| Company | Price | Shares | Total | Published | Completed |
|---|---|---|---|---|---|
| Neurocrine Biosciences, Inc. Common Stock US64125C1099 |
116.71 USD |
1,056 Sold |
123,245 USD |
12/02/2025 | 13/02/2025 |
| Neurocrine Biosciences, Inc. Common Stock US64125C1099 |
116.74 USD |
1,098 Sold |
128,183 USD |
12/02/2025 | 13/02/2025 |
| Neurocrine Biosciences, Inc. Common Stock US64125C1099 |
118.31 USD |
980 Sold |
115,940 USD |
08/02/2025 | 10/02/2025 |
| Neurocrine Biosciences, Inc. Common Stock US64125C1099 |
152.94 USD |
1,207 Sold |
184,599 USD |
31/01/2025 | 31/01/2025 |
| Neurocrine Biosciences, Inc. Common Stock US64125C1099 |
133.36 USD |
7,231 Sold |
964,359 USD |
15/04/2024 | 15/04/2024 |
| Neurocrine Biosciences, Inc. Common Stock US64125C1099 |
133.36 USD |
12,587 Sold |
1,678,660 USD |
15/04/2024 | 15/04/2024 |
| Neurocrine Biosciences, Inc. Common Stock US64125C1099 |
139.38 USD |
69,521 Sold |
9,689,761 USD |
14/03/2024 | 14/03/2024 |
| Neurocrine Biosciences, Inc. Common Stock US64125C1099 |
139.38 USD |
5,479 Sold |
763,657 USD |
14/03/2024 | 14/03/2024 |
| Neurocrine Biosciences, Inc. Common Stock US64125C1099 |
134.69 USD |
53,143 Sold |
7,157,730 USD |
28/02/2024 | 28/02/2024 |
| Neurocrine Biosciences, Inc. Common Stock US64125C1099 |
134.69 USD |
21,857 Sold |
2,943,878 USD |
28/02/2024 | 28/02/2024 |